Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease
Dan Liu, Honghua Zhang, Yuying Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114044-114044
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease
Honghua Zhang, Yuying Wang, Yuqing Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114606-114606
Closed Access | Times Cited: 54
Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease
Siew Lee Cheong, Jian Kai Tiew, Yi Hang Fong, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1560-1560
Open Access | Times Cited: 45
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents
Elisabetta Barresi, Emma Baglini, Valeria Poggetti, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2127-2127
Open Access | Times Cited: 13
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 11
The promising role of natural products in Alzheimer's disease
Michelle Melgarejo da Rosa, Luciclaudio Cassimiro de Amorim, João Victor de Oliveira Alves, et al.
Brain Disorders (2022) Vol. 7, pp. 100049-100049
Open Access | Times Cited: 28
Carbamate as a potential anti‐Alzheimer's pharmacophore: A review
Yash Pal Singh, Navneet Kumar, Brijesh Singh Chauhan, et al.
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1624-1651
Closed Access | Times Cited: 15
Discovery of novel dual acetylcholinesterase and butyrylcholinesterase inhibitors using machine learning and structure-based drug design
Manish Tripathi, Bhagwati Bhardwaj, Digambar Kumar Waiker, et al.
Journal of Molecular Structure (2023) Vol. 1286, pp. 135517-135517
Closed Access | Times Cited: 14
Antioxidants in Anti-Alzheimer's Disease Drug Discovery
Jianan Guo, Yalan Zhu, Jia Zhi, et al.
Ageing Research Reviews (2025) Vol. 107, pp. 102707-102707
Closed Access
A multi-target directed ligands strategy for the treatment of Alzheimer's disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 activator
Jie Guo, Maojun Cheng, Peng Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114630-114630
Closed Access | Times Cited: 21
Application of biomarker-derived fluorescent probes for the detection of Alzheimer's disease
Haitao Ding, Zhiqian Li, Kui Luo, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 169, pp. 117369-117369
Closed Access | Times Cited: 12
Multitarget-Directed Carbamate and Carbamothioate Derivatives: Cholinesterase and Monoamine Oxidase Inhibition, Anti-Β-Amyloid (Aβ) Aggregation, Antioxidant and Blood–Brain Barrier Permeation Properties Against Alzheimer's Disease
Senel Teke Tuncel, Sule Erol Gunal, İlke Demir, et al.
(2025)
Closed Access
Design, Synthesis, and Bio-Evaluation of C2-Aryl Galantamine Derivatives
Shuishu Wang, Wan-Sheng Ji, Lianhai Shan, et al.
(2025)
Closed Access
Myeloperoxidase as a therapeutic target for oxidative damage in Alzheimer’s disease
Astrid Mayleth Rivera Antonio, Itzia I. Padilla‐Martínez, Mónica Torres-Ramos, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Design, synthesis, biological evaluation, and in silico studies of imidazo[2,1-b][1,3,4]thiadiazole derivatives as cholinesterase inhibitors
Wen-Rong Du, Yixuan Wang, Xue-Wei Zhou, et al.
Medicinal Chemistry Research (2025)
Closed Access
Design, synthesis, and bio-evaluation of C1-aryl galantamine derivatives
Shuishu Wang, Wan-Sheng Ji, Longjiang Chen, et al.
Fitoterapia (2025) Vol. 183, pp. 106535-106535
Closed Access
Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease
Xueyan Liu, Chuanyu Yu, Yuxing Yao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115120-115120
Closed Access | Times Cited: 10
Synthesis and biological evaluation of substituted acetamide derivatives as potential butyrylcholinestrase inhibitors
Dehong Yu, Can Yang, Yi Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Design, synthesis, and biological evaluation of novel tryptanthrin derivatives as selective acetylcholinesterase inhibitors for the treatment of Alzheimer's disease
Jucheng Xia, Shuanghong Dong, Lili Yang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106980-106980
Closed Access | Times Cited: 9
Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer’s disease
Ningwei Wang, Wenlong Jia, Junqin Wang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107010-107010
Closed Access | Times Cited: 9
Design, Synthesis, and Activity Evaluation of Fluorine-Containing Scopolamine Analogues as Potential Antidepressants
Le Wang, Xushuo Zhu, Bo Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5391-5420
Closed Access | Times Cited: 3
Design, synthesis and biological evaluation of N-salicyloyl tryptamine derivatives as multifunctional neuroprotectants for the treatment of ischemic stroke
Genping Wu, Bo Li, Xiuzhen Wei, et al.
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116795-116795
Closed Access | Times Cited: 3
Novel Small Molecule-Based Acetylcholinesterase (AChE) Inhibitors: from Biological Perspective to Recent Developments
Anjali Sobha, A. Anand Ganapathy, Sangeetha Mohan, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100237-100237
Open Access | Times Cited: 3
Discovery of carbamate-based N-salicyloyl tryptamine derivatives as novel pleiotropic agents for the treatment of Alzheimer's disease
Yuying Wang, Honghua Zhang, Dan Liu, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105993-105993
Closed Access | Times Cited: 15
Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy
Honghua Zhang, Yan Peng, Linsheng Zhuo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114695-114695
Closed Access | Times Cited: 15
Supramolecular Tools to Improve Wound Healing and Antioxidant Properties of Abietic Acid: Biocompatible Microemulsions and Emulgels
A. B. Mirgorodskaya, R. A. Kushnazarova, Rais Pavlov, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6447-6447
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top